Stavzor Alternatives Compared
| Stavzor (valproic acid) | Vraylar (cariprazine) | Caplyta (lumateperone) |
|
|---|
| Stavzor (valproic acid) | Vraylar (cariprazine) | Caplyta (lumateperone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bipolar Disorder, Epilepsy, Seizure Prevention, Seizures, Migraine Prevention. Stavzor may also be used for purposes not listed in this medication guide. |
Prescription only
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to... View more |
Prescription only
Caplyta is an atypical antipsychotic that is used to treat adults with schizophrenia or depression associated with bipolar disorder. Sleepiness is the most common side effect and it should not be... View more |
||||||||||||||||
| More about Stavzor (valproic acid) | More about Vraylar (cariprazine) | More about Caplyta (lumateperone) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Stavzor has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Vraylar has an average rating of 6.0 out of 10 from a total of 513 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 33% reported a negative effect. |
Caplyta has an average rating of 6.5 out of 10 from a total of 182 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Lower cost generic approved | ||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Vraylar prices |
View all Caplyta prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other valproic acid brands include: Valproate Sodium |
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
16 hours |
504 hours |
18 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
When Treating Epilepsy
Category X
Not for use in pregnancy
When Treating Migraine See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 409 drugs are known to interact with Stavzor:
|
A total of 572 drugs are known to interact with Vraylar:
|
A total of 600 drugs are known to interact with Caplyta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
July 29, 2008 |
September 17, 2015 |
December 20, 2019 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.